rolofylline has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anglada-Huguet, M; Dennissen, FJ; Mandelkow, E; Mandelkow, EM; Sydow, A | 1 |
| Hsieh, CL; Huang, CP; Liao, HY; Lin, YW | 1 |
| Gottlieb, SS | 1 |
| Karasawa, A; Kusaka, H; Nagashima, K | 1 |
| Karasawa, A; Kusaka, H; Sato, K; Yao, K | 1 |
| Karasawa, A; Kusaka, H; Sano, J; Sato, K; Yao, K | 1 |
| Erley, CM; Heyne, N; Osswald, H; Risler, T; Yao, K | 1 |
1 review(s) available for rolofylline and Disease Models, Animal
| Article | Year |
|---|---|
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines | 2008 |
6 other study(ies) available for rolofylline and Disease Models, Animal
| Article | Year |
|---|---|
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.
Topics: Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Axons; Dendritic Spines; Disease Models, Animal; Fluorescent Antibody Technique; Gene Expression; Hippocampus; Humans; Memory, Long-Term; Mice; Mice, Transgenic; Mitochondria; Neurons; Phosphorylation; Protein Aggregates; Protein Aggregation, Pathological; Sequence Deletion; Synaptic Transmission; tau Proteins; Tauopathies; Xanthines | 2016 |
Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.
Topics: Acupuncture Analgesia; Adenosine; Analgesics, Opioid; Animals; Behavior, Animal; Biomarkers; Chromones; Disease Models, Animal; Electroacupuncture; Freund's Adjuvant; Gene Deletion; Gene Expression; Gene Knockout Techniques; Glial Fibrillary Acidic Protein; Male; Mice; Morpholines; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain; Pain Management; Proto-Oncogene Proteins c-akt; S100 Calcium Binding Protein beta Subunit; Signal Transduction; Spinal Cord Dorsal Horn; TOR Serine-Threonine Kinases; TRPV Cation Channels; Xanthines | 2017 |
Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.
Topics: Absorption; Acute Kidney Injury; Administration, Oral; Animals; Blood Urea Nitrogen; Cisplatin; Creatinine; Disease Models, Animal; Furosemide; Glomerular Filtration Rate; Injections, Intravenous; Kidney Tubules; Male; Potassium; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Renal Circulation; Sodium; Trichlormethiazide; Water; Xanthines | 1995 |
Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Disease Models, Animal; Furosemide; Gentamicins; Injections, Subcutaneous; Kidney; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Xanthines | 1994 |
Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in various models of acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Diuresis; Furosemide; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Xanthines | 1994 |
The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency.
Topics: Animals; Blood Pressure; Contrast Media; Diatrizoate; Disease Models, Animal; Diuretics; Diuretics, Osmotic; Enzyme Inhibitors; Glomerular Filtration Rate; Male; Mannitol; Nephrosis, Lipoid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Sodium; Xanthines | 2001 |